MILESTONE PHARMACEUTICALS IN's ticker is MIST and the CUSIP is 59935V107. A total of 34 filers reported holding MILESTONE PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $2,309,000 | +90.7% | 315,404 | -1.6% | 0.00% | – |
| Q2 2020 | $1,211,000 | +105.6% | 320,377 | 0.0% | 0.00% | – |
| Q1 2020 | $589,000 | -88.6% | 320,377 | -0.6% | 0.00% | -100.0% |
| Q4 2019 | $5,162,000 | -14.8% | 322,433 | -0.8% | 0.00% | 0.0% |
| Q3 2019 | $6,061,000 | -31.3% | 325,000 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $8,824,000 | – | 325,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 2,340,207 | $3,089,073 | 5.63% |
| Stonepine Capital Management, LLC | 1,239,199 | $1,635,743 | 1.50% |
| Alta Fundamental Advisers LLC | 2,658,589 | $3,509,337 | 1.11% |
| BML Capital Management, LLC | 1,102,895 | $1,455,821 | 1.04% |
| Altium Capital Management LP | 1,012,368 | $1,336,326 | 0.54% |
| Bleichroeder LP | 1,326,085 | $1,750,432 | 0.52% |
| Nantahala Capital Management | 1,750,000 | $2,310,000 | 0.14% |
| Ikarian Capital, LLC | 466,019 | $619,806 | 0.11% |
| RTW INVESTMENTS, LP | 3,256,102 | $4,298,055 | 0.07% |
| Orbimed Advisors | 2,000,000 | $2,640,000 | 0.05% |